The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Arab-Brazilian Chamber takes firms for Food Africa
- Forest Fund close to starting operations
- Jabuti Prize: Book on Arab world a semifinalist
- Bahrain Bourse enhances price discovery
- Brazil’s Pará eyes live buffalo exports to Morocco
- Oman’s economy expected to grow 4.5% in 2026
- Brazil chicken: UAE, Saudi purchases up 30%
- Jordan restores city to attract tourists
